Clopidogrel napadisilate
萘二磺酸氯吡格雷
Report date: 2023/01/10 17:56:57
First In Class
Base Information
Drug NameClopidogrel napadisilate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2010/11/01
Country/Territory +[5]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A